Zonisamide Capsules Recalled by Glenmark Due to CGMP Deviations
Glenmark Pharmaceuticals Inc., USA is voluntarily recalling Zonisamide Capsules USP 100 mg nationwide due to CGMP (Current Good Manufacturing Practice) deviations. The recall affects multiple lot numbers distributed from August 2021.
- Product
- ZONISAMIDE — ZONISAMIDE (ZONISAMIDE)
- Category
- Drug
- Distribution
- Distributed nationwide